← Apex Wire
Insider activity — NTLAIntellia Therapeutics, Inc.

5 Form 4 filings for NTLA between 2026-07-24 and 2026-11-03, from 4 filers. 4 discretionary (4 sales, 0 purchases), 1 routine grant or withholding filing. 4 of 5 carry a dollar total (3 stated, 1 computed as shares × price), summing to $509,148; a multi-transaction filing without a stated total contributes only its largest transaction, so the sum is a floor and the true figure is higher. Prices ran $11 to $13.

Filings 5 Filers 4 Discretionary 4 Routine 1 Structured 3/5

Filers
▸LEONARD JOHN MPresident and CEO 2026-11-03 · sold 9,000 @ $11.99 for $107,910 TOTAL SOLD ≥ $394,72910b5-1 ×22 filings
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-11-03 sold 10b5-1 PLAN 9,000 $11.99 $107,910 1 RECEIPT ↗
2026-08-24 sold 10b5-1 PLAN 19,890 $12.60 $286,819 2 RECEIPT ↗
▸Marantz Jing L.EVP, Chief Medical Officer 2026-10-28 · received (award/grant) 199,822 1 filing
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-10-28 received (award/grant) 199,822 — — 1 RECEIPT ↗
▸Dube Michael PVP, Chief Accounting Officer 2026-10-06 · sold 1,864 @ $12.43 for $23,170 TOTAL SOLD ≥ $23,1701 filing
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-10-06 sold 1,864 $12.43 $23,170 1 RECEIPT ↗
▸Dulac Edward J IIIrole unstated 2026-07-24 · sold 8,111 @ $11.25 1 filing
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-07-24 sold 8,111 $11.25 $91,249 — RECEIPT ↗

4 filers · 5 filings · disclosed filing totals sum to $509,148 (3/5 state one, 1 computed; totals are proceeds with a floor, never profit — a Form 4 states what was traded, not what it cost the filer)

Elsewhere